0001831410-26-000008.txt : 20260727 0001831410-26-000008.hdr.sgml : 20260727 20260727193005 ACCESSION NUMBER: 0001831410-26-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260723 FILED AS OF DATE: 20260727 DATE AS OF CHANGE: 20260727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harmon Cyrus CENTRAL INDEX KEY: 0001831410 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 261207132 MAIL ADDRESS: STREET 1: C/O OLEMA PHARMACEUTICALS, INC. STREET 2: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 form4-07272026_070701.xml X0609 4 2026-07-23 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001831410 Harmon Cyrus false C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST SAN FRANCISCO CA 94103 true false false false 0 Common Stock 2026-07-23 4 S 0 12500 11.579 D 715270 D Common Stock 2026-07-24 4 S 0 12500 11.714 D 702770 D Common Stock 117028 I See Footnote The weighted average sale price for the transaction reported was $11.579, and the range of prices were between $11.52 and $11.675. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $11.714, and the range of prices were between $11.70 and $11.775. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager. /s/ Shawnte Mitchell, Attorney-in-Fact 2026-07-27